 Recent Internal Control Issues Recent Disclosure Control Issues Recent Non-Timely Filing Recent Director/Officer Resignation
| Ticker |
CYTR (Nasdaq Smallcap Mkt) |
Auditor |
BDO Seidman LLP since 2004 |
| IRS Number |
58-1642740 |
CIK Code |
799698 SEC Filings |
| Fiscal Year End |
December 31st |
Accelerated Filer |
Yes, as of 30 September 2008 (10-Q 2008-11-07) |
| Business Address |
11726 SAN VICENTE BOULEVARD
SUITE 650
LOS ANGELES, CALIFORNIA 90049
(310) 826-5648 |
Mailing Address |
11726 SAN VICENTE BOULEVARD
SUITE 650
LOS ANGELES, CALIFORNIA 90049 |
| IPO Year |
1985 |
Company Website |
www.cytrx.com
|
| Index |
|
Industry |
SIC: 2836
Biological Products, Except Diagnostic Substances
NAICS: 325414
Biological Product (except Diagnostic) Manufacturing
|
| Market Cap |
$26,136,600 |
Shares Outstanding |
93,345,000 |
| Revenue (yr)** |
$6,317,920 |
Float |
88,785,000 |
| Revenue (mrq) |
$917,473 |
Short Interest |
1,371,830 (2008/12/10) |
| Earnings (mrq) |
$-12,315,500 |
Last Report |
10-Q (2008-11-07) |
| Book Value |
$18,362,800 |
Last Non-Timely Filing |
NT 10-Q (2008-05-13) More Detail >> |
| Assets |
$35,742,600 |
Last Securities Registration |
S-4/A (2008-08-07) |
Financial info as of 2008-09-30. ** Trailing twelve months.
| Restatements More Detail >> |
2007-11-13 8-K for the period from 2007-01-01 to 2007-06-30
2007-04-02 8-K for the period from 2005-01-01 to 2006-09-30
2006-04-03 NT 10-K for the period from 2005-01-01 to 2005-12-31
|
|
 |
| Auditor Changes More Detail >> |
2004-04-14 engaged BDO Seidman LLP
2004-04-12 dismissed PricewaterhouseCoopers LLP
2004-01-30 engaged PricewaterhouseCoopers LLP
2004-01-20 dismissed Ernst & Young LLP
|
|
| Director / Officer Changes More Detail >> |
| 2009-01-06 8-K | | Appointed John Y Caloz CA CFO | | Resigned Mitchell K Fogelman CFO | | Appointed Scott Wieland Senior VP of Drug Development | | | 2007-10-31 8-K | | Appointed John Y Caloz Chief Accounting Officer | | | 2007-09-12 8-K | | Appointed Mitchell K Fogelman CFO | | Resigned Matthew Natalizio CFO | | | 2007-05-21 8-K | | Employment Ceased Mark L Tepper PhD Senior VP of Drug Discovery | |
|
|
|
|
| Auditor Fees More Detail >> |
| Year |
Audit Fees |
Non-Audit Fees |
Total Fees |
| 2007 | $656,000 | $847,000 | $1,503,000 |
| 2006 | $815,000 | $138,000 | $953,000 |
| 2005 | $170,000 | $0 | $170,000 |
| 2004 | $217,000 | $20,000 | $237,000 |
| 2003 | $160,000 | $25,000 | $185,000 |
| 2002 | $238,200 | $14,190 | $252,390 |
| 2001 | $75,500 | $35,900 | $111,400 |
| 2000 | $68,000 | $68,000 | $136,000 |
|
|
|
| Audit Opinions More Detail >> |
| Year |
Auditor |
Auditor Location |
| 2007 | BDO Seidman LLP | Los Angeles, California |
| 2006 | BDO Seidman LLP | Los Angeles, California |
| 2005 | BDO Seidman LLP | Los Angeles, California |
| 2004 | BDO Seidman LLP | Los Angeles, California |
| 2003 | BDO Seidman LLP | Los Angeles, California |
| 2002 | Ernst & Young LLP | Atlanta, Georgia |
| 2001 | Ernst & Young LLP | Atlanta, Georgia |
| 2000 | Ernst & Young LLP | Los Angeles, California |
| 1999 | Ernst & Young LLP | Atlanta, Georgia |
|
|
| Controls More Detail >> |
| Period |
NT |
ICFR (404) - Auditor |
ICFR (404) - Management |
DC (302) - Management |
CIC (302) - Management |
| 20080930 10-Q | | | | a | |
| 20080630 10-Q | | | | | q |
| 20080331 10-Q | | | | | q |
| 20071231 10-K | | BDO Seidman LLP
|
| | |
| 20070930 10-Q | | | | | q |
| 20070630 10-Q | | | | | q |
| 20070331 10-Q | | | | | q |
| 20061231 10-K | | BDO Seidman LLP
|
| | |
| 20060930 10-Q | | | | a | |
| 20060630 10-Q | | | | | q |
| 20060331 10-Q | | | | | q |
| 20051231 10-K | | | | a | |
| 20050930 10-Q | | | | a | |
| 20050630 10-Q | | | | a | |
| 20050331 10-Q | | | | a | |
| 20041231 10-K | | | | a | |
| 20040930 10-Q | | | | a | |
| 20040630 10-Q | | | | a | |
| 20040331 10-Q | | | | a | |
| 20031231 10-K | | | | a | |
| 20030930 10-Q | | | | a | |
| 20030630 10-Q | | | | a | |
| 20030331 10-Q | | | | a | |
| 20021231 10-K | | | | a | |
| 20020930 10-Q | | | | | |
NT = Non-Timely or Late Filing Notification Issued for the Period
ICFR - Auditor = Internal Controls over Financial Reporting (SOX 404) - Auditor's Assessment
ICFR - Management = Internal Controls over Financial Reporting (SOX 404) - Management's Assessment
DC - Management = Disclosure Controls (SOX 302) - Management's Assessment
CIC - Management = Changes in Internal Controls (SOX 302) - Management's Disclosure
|
|
Company Transactions
| Description | Filings | Parties | Value ($) | Commenced | Closed | | Merger Agreement | 8-K 2008-06-09
8-K 2008-06-09
S-4/A 2008-08-07
S-4/A 2008-08-07
| | 3,000,000
(Estimate) | 2008-06-06 | 2008-09-19
(Estimate) | |
|
|
Audit + Compliance
Auditor Changes
Auditor Search
